Fermented Ginseng with Bifidobacterium Inhibits Angiogenesis of Human Umbilical Endothelial Cells in vitro and in vivo |
Ko, Yu-Jin
(College of Pharmacy, Yeungnam University)
Park, Seung-Hee (R&D Center, Jung San Biotechnology) Park, Byung-Chul (College of Pharmacy, Yeungnam University) Lee, Yong-Hwa (R&D Center, Jung San Biotechnology) Kim, Jung-Ae (College of Pharmacy, Yeungnam University) |
1 | Hasegawa, H., Sung, J.H., Matsumiya, S. and Uchiyama, M. (1996). Main ginseng saponin metabolites formed by intestinal bacteria. Planta Med. 62, 453-457 DOI ScienceOn |
2 | Liang, H.C., Chen, C.T., Chang, Y., Huang, Y.C., Chen, S.C. and Sung, H.W. (2005). Loading of a novel angiogenic agent, ginsenoside Rg1 in an acellular biological tissue for tissue regeneration. Tissue Eng. 11, 835-846 DOI ScienceOn |
3 | Akao, T., Kida, H., Kanaoka, M., Hattori, M. and Kobashi, K. (1998). Intestinal bacterial hydrolysis is required for the appearance of compound K in rat plasma after oral administration of ginsenoside Rb1 from Panax ginseng. J. Pharm. Pharmacol. 50, 1155-1160 DOI ScienceOn |
4 | Blouw, B., Song, H., Tihan, T., Bosze, J., Ferrara, N., Gerber, H.P., Johnson, R.S. and Bergers, G.. (2003). The hypoxic response of tumors is dependent on their microenvironment. Cancer Cell. 4, 133-146 DOI ScienceOn |
5 | Folkman, J. (1971). Tumor angiogenesis: therapeutic implications. N. Engl. J. Med. 285, 1182-1186 DOI ScienceOn |
6 | Hasegawa, H., Sung, J.H., Matsumiya, S., Uchiyama, M., Inoue, Y., Kasai, R. and Yamasaki, K. (1995). Reversal of daunomycin and vinblastin resistance in multidrug resistant P388 leukemia in vitro through enhanced cytotoxicity by triterpenoids. Planta Med. 61, 409-413 DOI ScienceOn |
7 | Hasegawa, H., Sung, J.H. and Huh J.D. (1997a). Ginseng intestinal bacteria metabolite IH901 as a new antimetastatic agent. Arch. Pharm. Res. 20, 539-544 DOI ScienceOn |
8 | Hasegawa, H., Sung, J.H. and Benno, Y. (1997b). Role of human intestinal Prevotella oris in hydrolyzing ginseng saponins. Planta Med. 63, 436-440 DOI ScienceOn |
9 | Hasegawa, H., Lee, K.S., Nagaoka, T., Tezuka, Y., Uchiyama, M., Kadota, S. and Saiki, I. (2000). Pharmacokinetics of ginsenoside deglycosylated by intestinal bacteria and its transformation to biologically active fatty acid esters. Biol. Pharm. Bull. 23, 298-304 DOI ScienceOn |
10 | Isner, J.M. and Asahara, T. (1999). Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularization. J. Clin. Invest. 103, 1231-1236 DOI ScienceOn |
11 | Lin, C.M., Chang, H., Chen, Y.H., Li, S.Y., Wu, I.H. and Chiu, J.H. (2006). Protective role of wogonin against lipopolysaccharide-induced angiogenesis via VEGFR-2, not VEGFR-1. Int. Immunopharmacol. 6, 1690-1698 DOI ScienceOn |
12 | Jin, J., Shahi, S., Kang, H.K., van Veen, H.W. and Fan, T.P. (2006). Metabolites of ginsenosides as novel BCRP inhibitors. Biochem. Biophys. Res. Commun. 345, 1308-1314 DOI ScienceOn |
13 |
Karikura, M., Miyase, T., Tanizawa, H., Taniyama, T. and Takino, Y. (1991). Studies on absorption, distribution, excretion and metabolism of ginseng saponins. VII. Comparison of the decomposition modes of |
14 | Leung, K.W., Pon, Y.L., Wong, R.N. and Wong, A.S. (2006). Ginsenoside-Rg1 induces vascular endothelial growth factor expression through the glucocorticoid receptor-related phosphatidylinositol 3-kinase/Akt and beta-catenin/T-cell factordependent pathway in human endothelial cells. J. Biol. Chem. 281, 36280-36288 DOI ScienceOn |
15 | Liu, C.X. and Xiao, P.G., (1992). Recent advances on ginseng research in China. Int. Immunopharmacol.36, 27-38 |
16 | Liu, W.K., Xu, S.X. and Che, C.T. (2000). Anti-proliferative effect of ginseng saponins on human prostate cancer cell line. Life Sci. 67, 1297-1306 DOI ScienceOn |
17 |
Mochizuki, M., Yoo, Y.C., Matsuzawa, K., Sato, K., Saiki, I., Tono-oka, S., Samukawa, K. and Azuma, I. (1995). Inhibitory effect of tumor metastasis in mice by saponins, ginsenoside- |
18 | Sengupta, S., Toh, S.A., Sellers, L.A., Skepper, J.N., Koolwijk, P., Leung, H.W., Yeung, H.W., Wong, R.N., Sasisekharan, R. and Fan, T.P. (2004). Modulating angiogenesis: the yin and the yang in ginseng. Circulation. 110, 1219-1225 DOI ScienceOn |
19 | Mousa, S.A., Mohamed, S., Wexler, E.J. and Kerr, J.S. (2005). Antiangiogenesis and anticancer efficacy of TA138, a novel alphavbeta3 antagonist. Anticancer Res. 25, 197-206 |
20 | Rosenblatt, M.I. and Azar, D.T. (2006). Anti-angiogenic therapy: Prospects for treatment of ocular tumors. Semin. Ophthalmol. 21, 151-160 DOI ScienceOn |
21 |
Yue, P.Y., Wong, D.Y., Wu, P.K., Leung, P.Y., Mak, N.K., Yeung, H.W., Liu, L., Cai, Z., Jiang, Z.H., Fan, T.P. and Wong, R.N. (2006). The angiosuppressive effects of 20(R)-ginsenoside |
22 | Yun, T.K., Lee, Y.S., Lee, Y.H., Kim, S.I. and Yun, H.Y. (2001). Anticarcinogenic effect of Panax ginseng C.A. Meyer and identification of active compounds. J. Korean Med. Sci. 16, S6-18 DOI |
23 | Shin, H.R., Kim, J.Y., Yun, T.K., Morgan, G. and Vainio, H. (2000). The cancer-preventive potential of Panax ginseng: a review of human and experimental evidence. Cancer Causes Control. 11, 565-576 DOI ScienceOn |
24 |
Shinkai, K., Akedo, H., Mukai, M., Imamura, F., Isoai, A., Kobayashi, M. and Kitagawa, I. (1996). Inhibition of in vitro tumor cell invasion by ginsenoside |
25 |
Xu, Q.F., Fang, X.L. and Chen, D.F. (2003). Pharmacokinetics and bioavailability of ginsenoside |
26 |
Tanizawa, H., Karikuma, M., Miyase, T. and Takino, Y. (1993). Studies on the metabolism and/or decomposition and distribution of ginsenoside |
![]() |